CPT 81258 HBA1/HBA2 Targeted Test Reimbursement

CPT code 81258 represents a targeted molecular diagnostic test for pathogenic variants in the alpha globin genes (HBA1/HBA2) that are linked to alpha thalassemia and some structural hemoglobinopathies. Nationally, this code matters because genetic confirmation of familial HBA variants guides diagnosis, reproductive counseling, and targeted clinical management, and it affects laboratory billing and coverage decisions for inherited hemoglobin disorders. Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will learn the clinical context for ordering CPT code 81258, typical sites of service where the test is performed, and the role of family-directed variant testing versus broader screening approaches. The summary covers payer coverage landscape and common billing considerations, plus operational benchmarks and policy updates relevant to molecular diagnostics. The content also summarizes coding nuances, documentation expectations, and areas where payer policies commonly vary, without providing clinical recommendations. Data not available in the input is noted where applicable.

Billing Code Overview

CPT code 81258 describes a laboratory molecular test that detects specific genetic changes in the alpha globin 1 and alpha globin 2 (HBA1/HBA) genes. The assay targets known familial variants associated with alpha thalassemia and certain structural hemoglobinopathies, focusing on variant detection in the patient's family line.

Service Type: Targeted genetic testing / molecular diagnostic analysis

Typical Site of Service: Clinical molecular laboratory; hospital laboratory; reference diagnostic laboratory

Data not available in the input.

Clinical Context

A 28-year-old woman with a family history of alpha thalassemia presents to a clinical genetics outpatient service for carrier testing prior to pregnancy. The patient reports that a sibling has been diagnosed with an alpha globin gene deletion. A genetics counselor documents the family pedigree and orders targeted molecular testing for known familial variants in the HBA1/HBA2 genes to confirm carrier status.

Specimen collection occurs at an ambulatory phlebotomy clinic or hospital outpatient laboratory. The blood sample is sent to a molecular diagnostics laboratory where a technologist performs targeted genetic testing focused on the specific alpha globin variants reported in the family. Results are reviewed by a molecular pathologist and released to the ordering genetics provider, who incorporates results into counseling and reproductive planning. Typical site of service: outpatient ambulatory laboratory or molecular diagnostics reference lab.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when reporting only the professional interpretation by a pathologist/laboratory director separate from the technical testing.
`TC`	Technical component

Taxonomy Code	Specialty	Notes
207Q00000X	Clinical Molecular Genetics	Providers who interpret and sign molecular diagnostic reports.
207Q00000X	Clinical Laboratory Medical Director	Pathologists or laboratory directors overseeing molecular testing.
2080P0005X	Medical Genetics & Genomics	Clinical geneticists ordering and interpreting hereditary hemoglobinopathy testing.
2084P0800X	Genetic Counseling	Genetic counselors coordinating family history and test selection.
207L00000X	Pathology	Laboratory pathologists involved in molecular diagnostics.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`D56.1`	Beta thalassemia trait	Hemoglobinopathy screening and differentiation from alpha thalassemia in family studies.
`D56.2`	Beta thalassemia intermedia	Part of hemoglobinopathy differential diagnosis; molecular testing may be performed to clarify genotype.
`D56.3`	Beta thalassemia major	Severe hemoglobinopathy where family testing may include alpha globin analysis for coexisting variants.
`D56.9`	Thalassemia, unspecified	General coding when thalassemia is present but specific type not documented; alpha globin testing may be ordered.
`Z14.0`	Genetic carrier (carrier) status	Billing for targeted familial variant testing to determine carrier status before conception.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`81256`	Alpha globin (HBA1, HBA2) gene analysis; common deletional variants	Alternative or complementary testing that detects common deletional alpha thalassemia variants; may be ordered if broader deletion analysis is needed.
`81257`	Alpha globin (HBA1, HBA2) gene analysis; single nucleotide variants, targeted	Used for targeted sequencing of known familial point variants in alpha globin genes; may be performed instead of or alongside `81258` depending on variant type.
`88240`	Chromosome analysis, peripheral blood; banding or karyotype	Occasionally ordered in complex hemoglobinopathy evaluations or when chromosomal abnormalities are suspected.
`81479`	Unlisted molecular pathology procedure	Used when a specific molecular assay does not have an established CPT and a lab-developed test for unusual alpha globin variants is performed.
`36415`	Collection of venous blood by venipuncture	Specimen collection code commonly billed when blood is collected for molecular testing.

OpenPayer

Summary & Overview

CPT 81258: Targeted HBA1/HBA2 Genetic Test for Alpha Thalassemia